Conference
Phase I/II study of GTI-2040 plus docetaxel as 2nd-line treatment in non-small cell lung cancer (NSCLC) and other solid tumors.
Authors
Leighl NB; Laurie SA; Knox JJ; Ellis PM; Shepherd FA; Burkes RL; Vincent M; Pond GR; Zwiebel JA; Moore MJ
Volume
23
Pagination
pp. 683S-683S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 1, 2005
Name of conference
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
Orlando, FL
Conference start date
May 13, 2005
Conference end date
May 17, 2005
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X